| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $820.2M | +31.1% |
| R&D Expense | $316.4M | +19.8% |
| SG&A Expense | $588.6M | +15.2% |
| Operating Income | -$541.0M | -15.6% |
| Interest Expense | $9.3M | +12.2% |
| Pre-tax Income | -$546.8M | -16.1% |
| Income Tax | $978K | +58.3% |
| Net Income | -$547.8M | -16.1% |
| EPS (Basic) | -$5.57 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $466.0M | +452.2% |
| Short-term Investments | $432.3M | -47.9% |
| Accounts Receivable | $244.4M | +100.2% |
| Inventory | $35.4M | +31.6% |
| Current Assets | $1.21B | +10.9% |
| Total Assets | $1.39B | +12.8% |
| Current Liabilities | $310.5M | +41.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$431.5M | -28.7% |
| Capital Expenditures | $47.7M | +16.2% |
| Investing Cash Flow | $330.3M | +261.0% |
| Financing Cash Flow | $482.6M | -16.2% |
| Free Cash Flow | -$479.2M | -27.4% |
| -6.9% |
| EPS (Diluted) | -$5.57 | -6.9% |
| Long-term Debt |
| $281.7M |
| +0.4% |
| Total Liabilities | $688.7M | +18.1% |
| Stockholders' Equity | $705.7M | +8.0% |